Diff for "Funding" - Bader Lab @ The University of Toronto

Differences between revisions 19 and 25 (spanning 6 versions)

Funding Agency		Title	Period
	Canadian Institutes of Health Research	A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324)	2007-2015
	Canadian Institutes of Health Research	From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant) Pls: Gary Bader, Philip Kim, Jason Moffat, Quaid Morris, Frederick Roth, Jacques Simard.	2015-2022
	Natural Sciences and Engineering Research Council of Canada	The Cancer Genome Collaboratory (Operating Grant: Discovery Frontiers) Pls: Lincoln Stein, Gary Bader, Alexandre Bouchard- Cote, Gillaume Bourque, Paul Boutros, Khaled El Emam, Vincent Ferretti, Bartha Knoppers, Francis Ouellette, Cenk Sahinalp, Sohrab Shah, Brian Shoichet.	2014-2018
	Natural Sciences and Engineering Research Council of Canada	Cell and tissue communication networks	2016-2021
	Ontario Institute for Cancer Research	Cancer stem cell program (Operating Grant) Pls: John Dick and Gary Bader	2013-2017
	Stand Up To Cancer	Activity 1: Discovery – Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) Pls: Peter Dirks, Samuel Weiss, Michael Taylor, Nada Jabado, Cheryl Arrowsmith, Michael Salter, Marco Marra, Mathieu Lupien, Amy Caudy, Trevor Pugh, Gary Bader, Michael Tyers, Wendy Durigon, Warren Mason, Eric Bouffet.	2015-2017
	Genome Canada	Activity 1: Identification and validation of the effect of common and low frequency genetic variants on breast cancer (Operating Sub-Grant) Pls: Jacques Simard and Gary Bader.	2013-2017
	Genome Canada	Activity 2: Identification and validation of the rare variants /mutations in novel breast cancer susceptibility (Operating Sub-Grant) Pls: Jacques Simard and Gary Bader.	2013-2017
	The Terry Fox Research Institute	Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) Pls: John Dick, Gary Bader.	2015-2020
	U.S. NIH via National Human Genome Research Institute (NHGRI)	Pathway Commons Research resource for biological pathways Pathway Commons is a collaboration between the Bader Lab at the University of Toronto, the Sander Lab at the cBio Center for Information Biology, Dana-Farber Cancer Institute and the Computational biology collaboratory at Harvard Medical School, and the Demir Lab, Oregon Health & Science University.	2008-2018
	U.S. NIH	Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research (Operating Sub-Grant: 69119295) PIs: Jill Mesirov and Gary Bader.	2006-2017
	U.S. NIH via National Center for Research Resources (NCRR)	Resource for Analysis, Vizualization, and Integration of Networks (RAVIN), PIs: Trey Ideker, Chris Sander, James Fowler, Bruce Conklin, Gary Bader, Benno Schwikowski. This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)	2010-2017
	U.S. NIH	A human binary interactome reference map by 2020 (Operational sub-grant:U41-HG001715-18). PIs: Marc Vidal, Michael Calderwood, David Hill, Frederick Roth.	2015-2018
	U.S. NIH via National Institute of General Medical Sciences (NIGMS)	Cytoscape: A Modeling Platform for Biomolecular Networks Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Institute of General Medical Sciences (NIGMS) under award number GM070743. PIs: Trey Ideker, Gary Bader, Alex Pico, Benno Schwikowski.	2009-2016
	Canada First Research Excellence Fund	Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson.	2016-2019
	Canada First Research Excellence Fund	Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley.	2016-2019

-  ⇤ ← Revision 19 as of 2013-06-13 04:59:54 → 
  Size: 3708
  Editor: GaryBader
  Comment:
+   ← Revision 25 as of 2017-01-13 14:27:14 → ⇥
  Size: 6478
  Editor: ShanGao
  Comment:
-Deletions are marked like this.
+Additions are marked like this.
 Line 4:
-||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]] ||Resource for Analysis, Vizualization, and Integration of Networks (RAVIN), PIs: Trey Ideker, Chris Sander, James Fowler, Bruce Conklin, Gary Bader, Benno Schwikowski.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2010-2015||
||<style="text-align: center;">{{attachment:ontario.gif}}||[[http://www.mri.gov.on.ca/english/programs/orf/gl2/program.asp|Global Leadership Round in Genomics & Life Sciences (GL2)]]||Cancer Gene Encyclopaedia (CGEP): Computationally optimized characterization of cancer genes, proteins, their structure, function and interactions. PIs: Igor Jurisica, Gary Bader, Lincoln Stein, Quaid Morris||2009-2015||
||<style="text-align: center;">{{attachment:ontario.gif}}||[[http://www.mri.gov.on.ca/english/programs/era/program.asp|Early Researcher Awards]]||Understanding how cellular systems are encoded in the genome||2010-2015||
||<style="text-align: center;">{{attachment:CIHR.gif}}||[[http://www.cihr-irsc.gc.ca/|The Canadian Institutes of Health Research]]||A combined computational and experimental approach to map protein interactions mediated by modular peptide recognition domains (Operating Grant MOP-84324)||2007-2015||
||<style="text-align: center;">{{attachment:nserc-web.png}}||[[http://nserc.ca/|Natural Sciences and Engineering Research Council of Canada]]||Molecular and genetic network analysis in yeast (Discovery Grant)||2007-2015||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]] ||Cytoscape: A Modeling Platform for Biomolecular Networks, PIs: Trey Ideker, Gary Bader, 2R01GM070743||2009-2013||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.genome.gov/|National Human Genome Research Institute (NHGRI)]] ||Pathway Commons: Research Resource for Biological Pathways, PIs: Chris Sander, Gary Bader, 1U41HG006623 (formerly 1 P41 P41HG04118)||2008-2015||
||<style="text-align: center;">{{attachment:GenomeCanada.jpg}} {{attachment:OGI.gif}}||[[http://www.genomecanada.ca/|Genome Canada]] via the [[http://www.ontariogenomics.ca|Ontario Genomics Institute]]||Software Tools to Simplify Gene Function Prediction, PIs: Quaid Morris, Gary Bader, 2007-OGI-TD-05||2008-2010||
||<style="text-align: center;">{{attachment:cfi.jpg}} {{attachment:ontario.gif}}||[[http://www.innovation.ca/|Canada Foundation for Innovation]] and [[http://www.mri.gov.on.ca/english/programs/ResearchFund.asp|Ontario Research Fund (ORF)]]||The Active Human Cell Map - Enabling Molecular and Genomic Medical Research (Leaders Opportunity Fund)||2008-2010||
||<style="text-align: center;">{{attachment:GenomeCanada.jpg}} {{attachment:OGI.gif}}||[[http://www.genomecanada.ca/|Genome Canada]] via the [[http://www.ontariogenomics.ca|Ontario Genomics Institute]]||Integrative Biology, PI: Brenda Andrews||2006-2010||
||<style="text-align: center;">{{attachment:UofTlogoSmall.gif}}||[[http://www.research.utoronto.ca/funding_internal/ff_i_csua.html|The University of Toronto, Connaught Committee]]||Start-up||2006||
+||<style="text-align:center;">{{attachment:CIHR.jpg}}||[[ http://www.cihr-irsc.gc.ca/|Canadian Institutes of Health Research]] || A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324)||2007-2015||
||<style="text-align:center;">{{attachment:CIHR.jpg}}||[[ http://www.cihr-irsc.gc.ca/|Canadian Institutes of Health Research]] ||From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant)<<BR>><<BR>>Pls: Gary Bader, Philip Kim, Jason Moffat, Quaid Morris, Frederick Roth, Jacques Simard.||2015-2022||
||<style="text-align:center;">{{attachment:NSERC.png||width=200}}||[[http://www.nserc-crsng.gc.ca/|Natural Sciences and Engineering Research Council of Canada]]||The Cancer Genome Collaboratory (Operating Grant: Discovery Frontiers) <<BR>><<BR>>Pls: Lincoln Stein, Gary Bader, Alexandre Bouchard- Cote, Gillaume Bourque, Paul Boutros, Khaled El Emam, Vincent Ferretti, Bartha Knoppers, Francis Ouellette, Cenk Sahinalp, Sohrab Shah, Brian Shoichet.||2014-2018||
||<style="text-align: center;">{{attachment:NSERC.png||width=200}}||[[http://www.nserc-crsng.gc.ca/|Natural Sciences and Engineering Research Council of Canada]]|| Cell and tissue communication networks||2016-2021||
||<style="text-align:center;">{{attachment:OICR.jpeg||width=150}}||[[ https://oicr.on.ca/oicr-programs-and-platforms/innovation-programs/cancer-stem-cell |Ontario Institute for Cancer Research]]||Cancer stem cell program (Operating Grant) <<BR>><<BR>>Pls: John Dick and Gary Bader||2013-2017||
||<style="text-align: center;">{{attachment:SU2C.jpg||width=200}}||[[http://www.standup2cancer.ca/en/dream_teams/view/cancer_stem_cell_dream_team/|Stand Up To Cancer]]||Activity 1: Discovery – Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) <<BR>><<BR>>Pls: Peter Dirks, Samuel Weiss, Michael Taylor, Nada Jabado, Cheryl Arrowsmith, Michael Salter, Marco Marra, Mathieu Lupien, Amy Caudy, Trevor Pugh, Gary Bader, Michael Tyers, Wendy Durigon, Warren Mason, Eric Bouffet.||2015-2017||
||<style="text-align:center;">{{attachment:Gen.jpg||width=220}}||[[https://www.genomecanada.ca/|Genome Canada]]|| Activity 1: Identification and validation of the effect of common and low frequency genetic variants on breast cancer (Operating Sub-Grant) <<BR>><<BR>>Pls: Jacques Simard and Gary Bader.||2013-2017||
||<style="text-align:center;">{{attachment:Gen.jpg||width=220}}||[[https://www.genomecanada.ca/|Genome Canada]]|| Activity 2: Identification and validation of the rare variants /mutations in novel breast cancer susceptibility (Operating Sub-Grant) <<BR>><<BR>>Pls: Jacques Simard and Gary Bader.||2013-2017||
||<style="text-align:center;">{{attachment:TerryFox.jpg||width=250}}||[[http://www.tfri.ca/|The Terry Fox Research Institute]]|| Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) <<BR>><<BR>>Pls: John Dick, Gary Bader.||2015-2020||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://genome.gov/|National Human Genome Research Institute (NHGRI)]]||Pathway Commons Research resource for biological pathways <<BR>><<BR>>[[http://www.pathwaycommons.org/|Pathway Commons]] is a collaboration between the Bader Lab at the University of Toronto, the Sander Lab at the cBio Center for Information Biology, Dana-Farber Cancer Institute and the Computational biology collaboratory at Harvard Medical School, and the Demir Lab, Oregon Health & Science University.||2008-2018||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]]||Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research (Operating Sub-Grant: 69119295) <<BR>><<BR>> PIs: Jill Mesirov and Gary Bader.||2006-2017||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]]||Resource for Analysis, Vizualization, and Integration of Networks (RAVIN), PIs: Trey Ideker, Chris Sander, James Fowler, Bruce Conklin, Gary Bader, Benno Schwikowski.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2010-2017||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]]|| [[http://interactome.baderlab.org/|A human binary interactome reference map by 2020]] (Operational sub-grant:U41-HG001715-18). <<BR>><<BR>> PIs: Marc Vidal, Michael Calderwood, David Hill, Frederick Roth. ||2015-2018||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]]||[[http://www.cytoscape.org/|Cytoscape: A Modeling Platform for Biomolecular Networks]]<<BR>><<BR>>Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Institute of General Medical Sciences (NIGMS) under award number GM070743. <<BR>><<BR>>PIs: Trey Ideker, Gary Bader, Alex Pico, Benno Schwikowski.||2009-2016||
||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). <<BR>><<BR>> PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson.||2016-2019||
||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). <<BR>><<BR>> PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley.|| 2016-2019||